Appendix II — C — Decisions Cited — C
Ninth Edition, Revision 01.2024
[ Editor Note: Opinions of the Patent Trial and Appeal Board or its predecessor organizations (Board) made available to the public after the Board first published Standard Operating Procedure 2 in 1994 (addressing the publication of Board opinions and the designation of such opinions as precedential) that (1) expressly indicate that the opinion is binding precedent of the Board or (2) are identified as binding precedent on the Board’s Precedential opinion website ( www.uspto.gov/patents-application-process/appealing -patent-decisions/decisions-and-opinions/precedential ) are precedential and binding authority. Prior to 1994, a decision by the Board was considered binding on panels of the Board only if the opinion was authorized by the Board to be published. See Ex parte Holt, 19 USPQ2d 1211 (Bd.Pat. App. & Int. 1991).]
Editor Note: When possible, parallel citations to the United States Reports or Federal Reporter and the United States Patent Quarterly (USPQ) are provided and include pinpoint pages, if appropriate. However, decisions of the U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit published after July 11, 2022, no longer contain a pinpoint page for the USPQ citations.
C, Ex parte, 27 USPQ2d 1492 (Bd. Pat. App. & Inter. 1992) 716.02(b) , 2133.03(a)
Cable Electric Products, Inc. v. Genmark, Inc., 770 F.2d 1015, 226 USPQ 881 (Fed. Cir. 1985) 716.03(b) , 716.06 , 1504.03
Cady, Ex parte, 1916 C.D. 62, 232 O.G. 621 (Comm’r Pat. 1916) 1502 , 1504.04
Caldwell, Ex parte, 1906 C.D. 58 (Comm’r Pat. 1906) 2173.05(d)
Callicrate vs. Wadsworth Mfg., Inc., 427 F.3d 1361, 77 USPQ2d 1041 (Fed. Cir. 2005) 2164.01
Campbell Soup Co. v. Gamon Plus, Inc., 10 F.4th 1268, 2021 USPQ2d 875 (Fed. Cir. 2021) 716.01(b) , 1504.03
Capon v. Eshhar, 418 F.3d 1349, 76 USPQ2d 1078 (Fed. Cir. 2005) 2161.01 , 2163
Card, Ex parte, 1904 C.D. 383 (Comm’r Pats. 1904) 2301.03
Cardiac Pacemakers, Inc. v. St. Jude Med., Inc., 296 F.3d 1106, 63 USPQ2d 1725 (Fed. Cir. 2002) 2181 , 2182
Carella v. Starlight Archery, 804 F.2d 135, 231 USPQ 644 (Fed. Cir. 1986) 2128 , 2132 , 2152.02(c)
Carl Zeiss Stiftung v. Renishaw PLC, 945 F.2d 1173, 20 USPQ2d 1094 (Fed. Cir. 1991) 2107.01 , 2107.02
Carletti, In re, 328 F.2d 1020, 140 USPQ 653 (CCPA 1964) 1504.01(c)
Carlson, In re, 983 F.2d 1032, 25 USPQ2d 1207 (Fed. Cir. 1992) 2126 , 2152.02(a)
Carman Indus. Inc. v. Wahl, 724 F.2d 932, 220 USPQ 481 (Fed. Cir. 1983) 804 , 1504.06
Carreira, In re, 532 F.2d 1356, 189 USPQ 461 (CCPA 1976) 716.10 , 2136.05
Carroll, In re, 601 F.2d 1184, 202 USPQ 571 (CCPA 1979) 716.01(c)
Carter, In re, 673 F.2d 1378, 213 USPQ 625 (CCPA 1982) 1504.03
Carter-Wallace, Inc. v. Riverton Labs., Inc., 433 F.2d 1034, 167 USPQ 656 (2d Cir. 1970) 2165.01
Case v. CPC Int’l Inc., 730 F.2d 745, 221 USPQ 196 (Fed. Cir. 1984) 2301.03
Casey, In re, 370 F.2d 576, 152 USPQ 235 (CCPA 1967) 2115
Catalina Mktg. Int’l v. Coolsavings.com, Inc., 289 F.3d 801, 62 USPQ2d 1781 (Fed. Cir. 2002) 2111.02
Catan, Ex parte, 83 USPQ2d 1569 (Bd. Pat. App. & Int. 2007) 2143 , 2143.01
Cataphote Corp. v. Desoto Chem. Coatings, Inc., 356 F.2d 24, 148 USPQ 229 (9th Cir. 1966) 2133.03(e)(1)
Caterpillar Inc. v. Deere & Co., 224 F.3d 1374, 56 USPQ2d 1305 (Fed. Cir. 2000) 2183 , 2184
Caterpillar Inc. v. Detroit Diesel Corp., 961 F. Supp. 1249, 41 USPQ2d 1876 (N.D. Ind. 1996) 2181
Caterpillar Tractor Co. v. Comm’r Pat., 650 F. Supp. 218, 231 USPQ 590 (E.D. Va. 1986) 1850
Cavanagh, In re, 436 F.2d 491, 168 USPQ 466 (CCPA 1971) 716.04
Caveney, In re, 761 F.2d 671, 226 USPQ 1 (Fed. Cir. 1985) 2133.03(b)
CCS Fitness, Inc. v. Brunswick Corp., 288 F.3d 1359, 62 USPQ2d 1658 (Fed. Cir. 2002) 2181
Celeritas Technologies Ltd. v. Rockwell International Corp., 150 F.3d 1354, 47 USPQ2d 1516 (Fed. Cir. 1998) 2123 , 2131.05
Cellect, LLC, In re, 81 F.4th 1216, 2023 USPQ2d 1011 (Fed. Cir. 2023) 1490
Centocor Ortho Biotech, Inc. v. Abbott Laboratories, 636 F.3d 1341, 97 USPQ2d 1870 (Fed. Cir. 2011) 2163
Certain Limited-Charge Cell Culture Microcarriers, In re, 221 USPQ 1165 (Int’l Trade Comm’n 1983) 2164.01
CFMT, Inc. v. Yieldup Int ’l Corp., 349 F.3d 1333, 68 USPQ2d 1940 (Fed. Cir. 2003) 2164
Chandler, In re, 319 F.2d 211, 138 USPQ 138 (CCPA 1963) 2173.05(n)
Chapman, In re, 357 F.2d 418, 148 USPQ 711 (CCPA 1966) 716.02(e)
Chef America, Inc. v. Lamb-Weston, Inc., 358 F.3d 1371, 69 USPQ2d 1857 (Fed. Cir. 2004) 2111.01
Chemcast Corp. v. Arco Indus. Corp., 913 F.2d 923, 16 USPQ2d 1033 (Fed. Cir. 1990) 2107.01 , 2161.01 , 2165.03 , 2411.01
Chemithon Corp. v. Procter & Gamble Co., 287 F. Supp 291, 159 USPQ 139 (D. Md. 1968) 2133.03(a)
Chester v. Miller, 906 F.2d 1574, 15 USPQ2d 1333 (Fed. Cir. 1990) 2731
Chevenard, In re, 139 F.2d 711, 60 USPQ 239 (CCPA 1943) 2144.03
Chicago Historical Antique Auto. Museum, Inc., In re, 197 USPQ 289 (Comm’r Pat. 1978) 513
Chicago Rawhide Mfg. Co., Ex parte, 223 USPQ 351 (Bd. Pat. App. & Inter. 1984) 2242 , 2258.01
Chicopee Mfg. Corp. v. Columbus Fiber Mills Co., 165 F. Supp. 307, 118 USPQ 53 (M.D. Ga. 1958) 2133.03(e)(1)
Chiddix, In re, 209 USPQ 78 (Comm’r Pat. 1980) 1205.02
Chilowsky, In re, 229 F.2d 457, 108 USPQ 321 (CCPA 1956) 2107.01 , 2107.02 , 2107.03 , 2164.02 , 2164.07
Chilowsky, In re, 306 F.2d 908, 134 USPQ 515 (CCPA 1962) 716.01(c)
Chiron Corp. v. Genentech Inc., 363 F.3d 1247, 70 USPQ2d 1321 (Fed. Cir. 2004) 2164.03 , 2164.05(a)
Chiuminatta Concrete Concepts, Inc. v. Cardinal Indus. Inc., 145 F.3d 1303, 46 USPQ2d 1752 (Fed. Cir. 1998) 2183 , 2184
Chore-Time Equipment, Inc. v. Cumberland Corp., 713 F.2d 774, 218 USPQ 673 (Fed. Cir. 1983) 2141.03
Chorna, In re, 656 Fed. App'x. 1016 (Fed. Cir. 2016) 2106.04(a)(1)
Christensen, In re, 330 F.2d 652, 141 USPQ 295 (CCPA 1964) 804.03
Chromalloy American Corp. v. Alloy Surfaces Co., 339 F. Supp 859, 173 USPQ 295 (D. Del. 1972) 2004 , 2012 , 2016
Chu, In re, 66 F.3d 292, 36 USPQ2d 1089 (Fed. Cir. 1995) 211.05 , 716.02(f)
Chudik v. Hirshfeld, 987 F.3d 1033, 2021 USPQ2d 149 (Fed. Cir. 2021) 2731
Chupp, In re, 816 F.2d 643, 2 USPQ2d 1437 (Fed. Cir. 1987) 716.01(d) , 716.02(a) , 2145
Ciric v. Flanigen, 511 F.2d 1182, 185 USPQ 103 (CCPA 1975) 2138.05
Citron, In re, 325 F.2d 248, 139 USPQ 516 (CCPA 1963) 2107.01 , 2107.02 , 2107.03
Clamp, In re, 151 USPQ 423 (Comm’r Pat. 1966) 213.03
Clapp, Ex parte, 227 USPQ 972 (Bd. Pat. App & Inter. 1985) 2142 , 2144
Clark, Ex parte, 174 USPQ 40 (Bd. App. 1971) 2173.05(o)
Clark, In re, 522 F.2d 623, 187 USPQ 209 (CCPA 1975) 2012 , 2012.01 , 2016
Clark, In re, 457 F.2d 1004, 173 USPQ 359 (CCPA 1972) 715.05
Clarke, In re, 356 F.2d 987, 148 USPQ 665 (CCPA 1966) 715.02 , 715.03
Clarke, In re, 809 Fed. Appx. 787, 2020 USPQ2d 10253 (Fed. Cir. 2020) 2111.01
Classen Immunotherapies, Inc. v. Biogen IDEC, 659 F.3d 1057, 100 USPQ2d 1492 (Fed. Cir. 2011) 2106.04(a)(1) , 2106.05 , 2106.05(d) , 2106.05(e)
Clay, In re, 966 F.2d 656, 23 USPQ2d 1058 (Fed. Cir. 1992) 2141.01(a) , 2144.08
Clearone, Inc. v. Shure Acquisition Holdings, Inc., 35 F.4th 1345, 2022 USPQ2d 509 (Fed. Cir. 2022) 2173.05(b)
ClearValue Inc. v. Pearl River Polymers Inc., 668 F.3d 1340, 101 USPQ2d 1773 (Fed. Cir. 2012) 2131.03
Clemens, In re, 622 F.2d 1029, 206 USPQ 289 (CCPA 1980) 716.02(d) , 2145
Clement, In re, 131 F.3d 1464, 45 USPQ2d 1161 (Fed. Cir. 1997) 1412.02
Cleveland Clinic Foundation v. True Health Diagnostics, LLC, 859 F.3d 1352, 123 USPQ2d 1081 (Fed. Cir. 2017) 2106.04(b) , 2106.05(a) , 2106.05(d)
Clifford, Ex parte, 49 USPQ 152 (Bd. App. 1940) 901.02
Clinical Products Ltd. v. Brenner, 255 F. Supp. 131, 149 USPQ 475 (D.D.C. 1966) 2173.05(q)
Cloud v. Standard Packaging Corp., 376 F.2d 384, 153 USPQ 317 (7th Cir. 1967) 2133.03(e)(1)
CMS Industries, Inc. v. L.P.S. International, Ltd., 643 F.2d 289, 217 USPQ 20 (5th Cir. 1981) 317.03
Coca-Cola Co. v. Gemini Rising Inc., 346 F. Supp. 1183, 175 USPQ 56 (E.D.N.Y. 1972) 1512
Cochrane v. Deener, 94 U.S. 780, 24 L.Ed. 139 (1876) 2106.03
Cofer, In re, 354 F.2d 664, 148 USPQ 268 (CCPA 1966) 2144.04
Cogar v. Schuyler, 464 F.2d 747, 173 USPQ 389 (D.C. Cir. 1972) 409.03(i)
Cohn, In re, 438 F.2d 984, 169 USPQ 95 (CCPA 1971) 2173.03
Colbert v. Lofdahl, 21 USPQ2d 1068 (Bd. Pat. App. & Inter. 1991) 2138.02
Cole, In re, 326 F.2d 769, 140 USPQ 230 (CCPA 1964) 2164.06(c)
Cole v. Kimberly-Clark Corp., 102 F.3d 524, 41 USPQ2d 1001 (Fed. Cir. 1996) 2181
Coleman v. Dines, 754 F.2d 353, 224 USPQ 857 (Fed. Cir. 1985) 2138.04
Colianni, In re, 561 F.2d 220, 195 USPQ 150 (CCPA 1977) 2164.06 , 2164.06(b)
Collier, In re, 397 F.2d 1003, 158 USPQ 266 (CCPA 1968) 2163 , 2163.05 , 2172.01 , 2173.05(k)
Comiskey, In re, 554 F.3d 967, 89 USPQ2d 1655 (Fed. Cir. 2009) 2106.04(a)(1)
Commonwealth Scientific, In re, 632 Fed. App'x. 1024 (Fed. Cir. 2015) 2304.02(c)
Comstock, In re, 481 F.2d 905, 178 USPQ 616 (CCPA 1973) 2164.06(c)
Comstock, Ex parte, 317 O.G. 4, 1923 C.D. 82 (Comm’r Pat. 1923) 1214.01
Conover v. Downs, 35 F.2d 59 (CCPA 1929) 1451
Consolidated Aluminum Corp. v. Foseco Inc., 910 F.2d 804, 15 USPQ2d 1481 (Fed. Cir. 1990) 2165
Consolidated Fruit-Jar Co. v. Wright, 94 U.S. 92 (1876) 2133.03(b) , 2134
Constant v. Advanced Micro-Devices, Inc., 848 F.2d 1560, 7 USPQ2d 1057 (Fed. Cir. 1988) 2128 , 2128.01 , 2128.02 , 2129 , 2141.01 , 2145 , 2152.03
Construction Equipment Company, In re, 665 F.3d 1254, 100 USPQ2d 1922 (Fed. Cir. 2011) 2259
Content Extraction and Transmission, LLC v. Wells Fargo Bank, 776 F.3d 1343, 113 USPQ2d 1354 (Fed. Cir. 2014) 2106.04(a) , 2106.04(a)(1) , 2106.04(a)(2) , 2106.05(d) , 2106.07(a)
Contessa Food Prods., Inc. v. Conagra, Inc., 282 F.3d 1370, 62 USPQ2d 1065 (Fed. Cir. 2002) 1504.04
Continental Can Co., Inc. v. Schuyler, 326 F. Supp 283, 168 USPQ 625 (D.D.C. 1970) 1216.01
Continental Can Co. v. Monsanto Co., 948 F.2d 1264, 20 USPQ2d 1746 (Fed. Cir. 1991) 2131.01
Convolve, Inc. v. Compaq Computer Corp., 527 Fed. App'x. 910 (Fed. Cir. 2013) 2161.01
Cook, In re, 439 F.2d 730, 169 USPQ 298 (CCPA 1971) 2164.03 , 2164.08(b)
Cooper v. Goldfarb, 154 F.3d 1321, 47 USPQ2d 1896 (Fed. Cir. 1998) 2163
Cooper v. Goldfarb, 240 F.3d 1378, 57 USPQ2d 1990 (Fed. Cir. 2001) 2138.05
Cooper Techs. Co. v. Dudas, 536 F.3d 1330, 87 USPQ2d 1705 (Fed. Cir. 2008) 2730
Copenhaver, Ex parte, 109 USPQ 118 (Bd. Pat. App. & Inter. 1955) 2173.05(b)
Corba, In re, 212 USPQ 825 (Comm’r Pat. 1981) 1504.20
Cordova, Ex parte, 10 USPQ2d 1949 (Bd. Pat. App. & Inter. 1989) 2173.05(h)
Corephotonics, Ltd. v. Apple Inc., 84 F.4th 990, 2023 USPQ2d 1202 (Fed. Cir. 2023) 2141.01(a)
Corkill, In re, 771 F.2d 1496, 226 USPQ 1005 (Fed. Cir. 1985) 716.02(a) , 2107.02
Cormany, In re, 476 F.2d 998, 177 USPQ 450 (CCPA 1973) 2172
Corneil, In re, 347 F.2d 563, 145 USPQ 702 (CCPA 1965) 2124
Corning Glass Works v. Sumitomo Elec. U.S.A., Inc., 868 F.2d 1251, 9 USPQ2d 1962 (Fed. Cir. 1989) 2111.02 , 2163
Corning v. Burden, 56 U.S. 252, 14 L.Ed. 683 (1854) 2106.03 , 2106.05(c)
Cornwall, In re, 230 F.2d 457, 109 USPQ 57 (CCPA 1956) 1504.02 , 1504.03
Correge v. Murphy, 705 F.2d 1326, 217 USPQ 753 (Fed. Cir. 1983) 2138.03
Cortright, In re, 165 F.3d 1353, 49 USPQ2d 1464 (Fed. Cir. 1999) 2111 , 2164.04
Costello, In re, 717 F.2d 1346, 219 USPQ 389 (Fed. Cir. 1983) 716.10 , 2136.05 , 2137 , 2138 , 2138.04 , 2138.05
Cowles, In re, 156 F.2d 551, 70 USPQ 419 (CCPA 1946) 1207.03 , 1207.03(a)
Craig, In re, 411 F.2d 1333, 162 USPQ 157 (CCPA 1969) 2190
Credit Acceptance Corp. v. Westlake Services, 859 F.3d 1044, 123 USPQ2d 1100 (Fed. Cir. 2017) 2106.04(a) , 2106.04(a)(1) , 2106.05(a)
Crish, In re, 393 F.3d 1253, 73 USPQ2d 1364 (Fed. Cir. 2004) 2111.03 , 2112
Critikon, Inc. v. Becton Dickinson Vascular Access, Inc., 120 F.3d 1253, 43 USPQ2d 1666 (Fed. Cir. 1997) 2001.06(c)
Crockett, In re, 279 F.2d 274, 126 USPQ 186 (CCPA 1960) 2144.06
Crocs Inc. v. International Trade Commission, 598 F.3d 1294, 93 USPQ2d 1777 (Fed. Cir. 2010) 1504.03 , 2143
Cross Med. Prods., Inc. v. Medtronic Sofamor Danek, Inc., 424 F.3d 1293, 76 USPQ2d 1662 (Fed. Cir. 2005) 2144
Cronyn, In re, 890 F.2d 1158, 13 USPQ2d 1070 (Fed. Cir.1989) 2128.01 , 2152.02(e)
Crosby, In re, 157 F.2d 198, 71 USPQ 73 (CCPA 1946) 716.07
Cross v. Iizuka, 753 F.2d 1040, 224 USPQ 739 (Fed. Cir. 1985) 2107.01 , 2107.03 , 2164.02
Crossman, In re, 187 USPQ 367 (PTO Solicitor 1975) 103
Cruciferous Sprout Litig., In re, 301 F.3d 1343, 64 USPQ2d 1202 (Fed. Cir. 2002) 2111.02
Crystal Semiconductor Corp. v. TriTech Microelectronics Int’l Inc., 246 F.3d 1336, 57 USPQ2d 1953 (Fed. Cir. 2001) 2111.03
CTS Corp. v. Electro Materials Corp. of America, 469 F. Supp. 801, 202 USPQ 22 (S.D. N.Y. 1979) 2133.03(b)
CTS Corp. v. Piher Int’l Corp., 593 F.2d 777, 201 USPQ 649 (7th Cir. 1979) 2133.03(d)
Cubist Pharm. Inc. v. Hospira, Inc., 805 F.3d 1112, 117 USPQ2d 1054 (Fed. Cir. 2015) 2163
Curtis, In re, 354 F.3d 1347, 69 USPQ2d 1274 (Fed. Cir. 2004) 2163 , 2163.05
Curver Luxembourg, SARL v. Home Expressions, Inc., 938 F.3d 1334, 2019 USPQ2d 341902 (Fed. Cir. 2019) 1502 , 1503.01
Custom Accessories, Inc. v. Jeffrey-Allan Industries, Inc., 807 F.2d 955, 1 USPQ2d 1196 (Fed. Cir. 1986) 2141 , 2141.03
CyberSource Corp. v. Retail Decisions, Inc., 654 F.3d 1366, 99 USPQ2d 1690 (Fed. Cir. 2011) 2106.04(a)(1) , 2106.05 , 2106.05(b) , 2106.05(c) , 2106.05(g)
Cyclobenzaprine Hydrochloride Extended- Release Capsule Patent Litig., In re, 676 F.3d 1063, 102 USPQ2d 1760 (Fed. Cir. 2012) 2145
Cited authority
- 716.02(b) Burden on Applicant
- 2133.03(a) “Public Use”
- 716.03(b) Commercial Success Derived From Claimed Invention
- 716.06 Copying
- 1504.03 Nonobviousness
- 1502 Definition of a Design
- 1504.04 Considerations Under 35 U.S.C. 112
- 2173.05(d) Exemplary Claim Language (“for example,” “such as”)
- 2164.01 Test of Enablement
- 716.01(b) Nexus Requirement and Evidence of Nonobviousness
- 2161.01 Computer Programming, Computer Implemented Inventions, and 35 U.S.C. 112(a) or Pre-AIA 35 U.S.C. 112, First Paragraph
- 2163 Guidelines for the Examination of Patent Applications Under the 35 U.S.C. 112(a) or Pre-AIA 35 U.S.C. 112, first paragraph, “Written Description” Requirement
- 2301.03 Interfering Subject Matter
- 2181 Identifying and Interpreting a 35 U.S.C. 112(f) or Pre-AIA 35 U.S.C. 112, Sixth Paragraph Limitation
- 2182 Search and Identification of the Prior Art
- 2128 “Printed Publications” as Prior Art
- 2132 Pre-AIA 35 U.S.C. 102(a)
- 2152.02(c) In Public Use
- 2107.01 General Principles Governing Utility Rejections
- 2107.02 Procedural Considerations Related to Rejections for Lack of Utility
- 1504.01(c) Lack of Ornamentality
- 2126 Availability of a Document as a “Patent” for Purposes of Rejection Under 35 U.S.C. 102(a) or Pre-AIA 35 U.S.C. 102(a), (b), and (d)
- 2152.02(a) Patented
- 804 Definition of Double Patenting
- 1504.06 Double Patenting
- 716.10 Attribution Affidavit or Declaration to Overcome Rejection Under Pre-AIA 35 U.S.C. 102 or 103
- 2136.05 Overcoming a Rejection Under Pre-AIA 35 U.S.C. 102(e)
- 716.01(c) Probative Value of Objective Evidence
- 2165.01 Considerations Relevant to Best Mode
- 2115 Material or Article Worked Upon by Apparatus
- 2111.02 Effect of Preamble
- 2143 Examples of Basic Requirements of a Prima Facie Case of Obviousness
- 2143.01 Suggestion or Motivation To Modify the References
- 2133.03(e)(1) Commercial Exploitation
- 2183 Making a Prima Facie Case of Equivalence
- 2184 Determining Whether an Applicant Has Met the Burden of Proving Nonequivalence After a Prima Facie Case Is Made
- 1850 Unity of Invention Before the International Searching Authority
- 716.04 Long-Felt Need and Failure of Others
- 2133.03(b) “On Sale”
- 2123 Rejection Over Prior Art’s Broad Disclosure Instead of Preferred Embodiments
- 2131.05 Nonanalogous or Disparaging Prior Art
- 1490 Disclaimers
- 2164 The Enablement Requirement
- 2173.05(n) Multiplicity
- 716.02(e) Comparison With Closest Prior Art
- 2111.01 Plain Meaning
- 2165.03 Requirements for Rejection for Lack of Best Mode
- 2411.01 Rejections Based on Deposit Issue
- 2731 Period of Adjustment
- 2144.03 Reliance on Common Knowledge in the Art or “Well Known” Prior Art
- 513 Deposit as Priority Mail Express® with U.S. Postal Service
- 2242 Criteria for Deciding Request Filed under 35 U.S.C. 302
- 2258.01 Use of Previously Cited/Considered Art in Rejections
- 1205.02 Appeal Brief Content
- 2107.03 Special Considerations for Asserted Therapeutic or Pharmacological Utilities
- 2164.02 Working and Prophetic Examples
- 2164.07 Relationship of Enablement Requirement to Utility Requirement of 35 U.S.C. 101
- 2164.03 Relationship of Predictability of the Art and the Enablement Requirement
- 2164.05(a) Specification Must Be Enabling as of the Filing Date
- 2141.03 Level of Ordinary Skill in the Art
- 2106.04(a)(2) Abstract Idea Groupings
- 804.03 Commonly Owned Inventions of Different Inventive Entities; Non-Commonly Owned Inventions Subject to a Joint Research Agreement
- 2004 Aids to Compliance With Duty of Disclosure
- 2012 Reissue Applications Involving Issues of Fraud, Inequitable Conduct, and/or Violation of Duty of Disclosure
- 2016 Fraud, Inequitable Conduct, or Violation of Duty of Disclosure Affects All Claims
- 211.05 Sufficiency of Disclosure in Prior-Filed Application
- 716.02(f) Advantages Disclosed or Inherent
- 716.01(d) Weighing Objective Evidence
- 716.02(a) Evidence Must Show Unexpected Results
- 2145 Consideration of Applicant’s Rebuttal Arguments and Evidence
- 2138.05 “Reduction to Practice”
- 213.03 Time for Filing U.S. Nonprovisional Application
- 2142 Legal Concept of Prima Facie Obviousness
- 2144 Supporting a Rejection Under 35 U.S.C. 103
- 2173.05(o) Double Inclusion
- 2012.01 Collateral Estoppel
- 715.05 U.S. Patent or Application Publication Claiming Same Invention
- 715.02 How Much of the Claimed Invention Must Be Shown, Including the General Rule as to Generic Claims
- 715.03 Genus-Species, Practice Relative to Cases Where Predictability Is in Question
- 2106.05 Eligibility Step 2B: Whether a Claim Amounts to Significantly More
- 2106.05(d) Well-Understood, Routine, Conventional Activity
- 2106.05(e) Other Meaningful Limitations
- 2141.01(a) Analogous and Nonanalogous Art
- 2144.08 Obviousness of Species When Prior Art Teaches Genus
- 2173.05(b) Relative Terminology
- 2131.03 Anticipation of Ranges
- 716.02(d) Unexpected Results Commensurate in Scope With Claimed Invention
- 1412.02 Recapture of Canceled Subject Matter
- 2106.04(b) Laws of Nature, Natural Phenomena & Products of Nature
- 2106.05(a) Improvements to the Functioning of a Computer or To Any Other Technology or Technical Field
- 901.02 Abandoned Applications
- 2173.05(q) “Use” Claims
- 317.03 Effect of Recording
- 1512 Relationship Between Design Patent, Copyright, and Trademark
- 2106.03 Eligibility Step 1: The Four Categories of Statutory Subject Matter
- 2144.04 Legal Precedent as Source of Supporting Rationale
- 409.03(i) Rights of the Nonsigning Inventor
- 2173.03 Correspondence Between Specification and Claims
- 2138.02 “The Invention Was Made in This Country”
- 2164.06(c) Examples of Enablement Issues – Computer Programming Cases
- 2138.04 “Conception”
- 2164.06 Quantity of Experimentation
- 2164.06(b) Examples of Enablement Issues — Biological and Chemical Cases
- 2163.05 Changes to the Scope of Claims
- 2172.01 Unclaimed Essential Subject Matter
- 2173.05(k) Aggregation
- 2304.02(c) Explaining Priority
- 1214.01 Procedure Following New Ground of Rejection by Board
- 1451 Divisional Reissue Applications; Continuation Reissue Applications Where the Parent is Pending
- 2165 The Best Mode Requirement
- 2134 Pre-AIA 35 U.S.C. 102(c)
- 2128.01 Level of Public Accessibility Required
- 2128.02 Date Publication Is Available as a Reference
- 2129 Admissions as Prior Art
- 2141.01 Scope and Content of the Prior Art
- 2152.03 Admissions
- 2259 Res Judicata and Collateral Estoppel in Reexamination Proceedings
- 2106.04(a) Abstract Ideas
- 2106.07(a) Formulating a Rejection For Lack of Subject Matter Eligibility
- 1216.01 Appeals to the U.S. Court of Appeals for the Federal Circuit
- 2131.01 Multiple Reference 35 U.S.C. 102 Rejections
- 2164.08(b) Inoperative Subject Matter
- 2730 Applications Filed on or After May 29, 2000; Grounds for Adjustment
- 1504.20 Benefit Under 35 U.S.C. 120
- 2173.05(h) Alternative Limitations
- 2172 Subject Matter Which the Inventor or a Joint Inventor Regards as The Invention
- 2124 Exception to the Rule That the Reference Must be Prior Art
- 2106.05(c) Particular Transformation
- 1504.02 Novelty
- 2138.03 “By Another Who Has Not Abandoned, Suppressed, or Concealed It”
- 2111 Claim Interpretation; Broadest Reasonable Interpretation
- 2164.04 Burden on the Examiner Under the Enablement Requirement
- 2137 Pre-AIA 35 U.S.C. 102(f)
- 2138 Pre-AIA 35 U.S.C. 102(g)
- 1207.03 New Ground of Rejection in Examiner’s Answer
- 1207.03(a) Determining Whether a Ground of Rejection is New
- 2190 Prosecution Laches and Res Judicata
- 2111.03 Transitional Phrases
- 2112 Requirements of Rejection Based on Inherency; Burden of Proof
- 2001.06(c) Information From Related Litigation and/or Trial Proceedings
- 2144.06 Art Recognized Equivalence for the Same Purpose
- 2152.02(e) Otherwise Available to the Public
- 716.07 Inoperability of References
- 103 Right of Public To Inspect Patent Files and Some Application Files
- 2133.03(d) “In This Country”
- 1503.01 Specification
- 2141 Examination Guidelines for Determining Obviousness Under 35 U.S.C. 103
- 2106.05(b) Particular Machine
- 2106.05(g) Insignificant Extra-Solution Activity